nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—lung cancer	0.0861	0.135	CbGbCtD
Zaleplon—CYP3A5—Gefitinib—lung cancer	0.0461	0.0722	CbGbCtD
Zaleplon—CYP3A5—Teniposide—lung cancer	0.0447	0.07	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0333	0.0521	CbGbCtD
Zaleplon—CYP3A7—Paclitaxel—lung cancer	0.0333	0.0521	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—lung cancer	0.0328	0.0514	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0328	0.0514	CbGbCtD
Zaleplon—CYP3A5—Crizotinib—lung cancer	0.0283	0.0443	CbGbCtD
Zaleplon—CYP3A5—Erlotinib—lung cancer	0.0273	0.0427	CbGbCtD
Zaleplon—CYP3A5—Paclitaxel—lung cancer	0.025	0.0391	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—lung cancer	0.0246	0.0386	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.024	0.0377	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—lung cancer	0.024	0.0377	CbGbCtD
Zaleplon—CYP3A5—Etoposide—lung cancer	0.0197	0.0309	CbGbCtD
Zaleplon—CYP3A4—Topotecan—lung cancer	0.0197	0.0308	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—lung cancer	0.018	0.0283	CbGbCtD
Zaleplon—CYP3A4—Gefitinib—lung cancer	0.018	0.0282	CbGbCtD
Zaleplon—CYP3A4—Teniposide—lung cancer	0.0174	0.0273	CbGbCtD
Zaleplon—CYP3A4—Vinorelbine—lung cancer	0.0138	0.0217	CbGbCtD
Zaleplon—CYP3A4—Crizotinib—lung cancer	0.011	0.0173	CbGbCtD
Zaleplon—CYP3A4—Erlotinib—lung cancer	0.0106	0.0166	CbGbCtD
Zaleplon—CYP3A4—Paclitaxel—lung cancer	0.00973	0.0152	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—lung cancer	0.0096	0.015	CbGbCtD
Zaleplon—CYP3A4—Vinblastine—lung cancer	0.00853	0.0134	CbGbCtD
Zaleplon—CYP3A4—Etoposide—lung cancer	0.00769	0.012	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—lung cancer	0.00703	0.011	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—lung cancer	0.00524	0.00821	CbGbCtD
Zaleplon—Hyperhidrosis—Paclitaxel—lung cancer	0.000111	0.000397	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—lung cancer	0.000111	0.000396	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Cisplatin—lung cancer	0.00011	0.000395	CcSEcCtD
Zaleplon—Anaemia—Docetaxel—lung cancer	0.00011	0.000394	CcSEcCtD
Zaleplon—Depression—Methotrexate—lung cancer	0.00011	0.000392	CcSEcCtD
Zaleplon—Anorexia—Paclitaxel—lung cancer	0.000109	0.000392	CcSEcCtD
Zaleplon—Hypotension—Etoposide—lung cancer	0.000109	0.000392	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—lung cancer	0.000109	0.000391	CcSEcCtD
Zaleplon—Pain—Cisplatin—lung cancer	0.000109	0.000391	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—lung cancer	0.000109	0.00039	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000109	0.00039	CcSEcCtD
Zaleplon—Body temperature increased—Gemcitabine—lung cancer	0.000108	0.000388	CcSEcCtD
Zaleplon—Rash—Vinorelbine—lung cancer	0.000108	0.000385	CcSEcCtD
Zaleplon—Dermatitis—Vinorelbine—lung cancer	0.000108	0.000385	CcSEcCtD
Zaleplon—Hypotension—Paclitaxel—lung cancer	0.000107	0.000384	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—lung cancer	0.000107	0.000384	CcSEcCtD
Zaleplon—Headache—Vinorelbine—lung cancer	0.000107	0.000383	CcSEcCtD
Zaleplon—Syncope—Docetaxel—lung cancer	0.000107	0.000383	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—lung cancer	0.000107	0.000383	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—lung cancer	0.000107	0.000382	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—lung cancer	0.000107	0.000382	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—lung cancer	0.000106	0.000378	CcSEcCtD
Zaleplon—Sweating—Methotrexate—lung cancer	0.000105	0.000377	CcSEcCtD
Zaleplon—Palpitations—Docetaxel—lung cancer	0.000105	0.000377	CcSEcCtD
Zaleplon—Feeling abnormal—Cisplatin—lung cancer	0.000105	0.000377	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—lung cancer	0.000105	0.000376	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—lung cancer	0.000105	0.000375	CcSEcCtD
Zaleplon—Loss of consciousness—Docetaxel—lung cancer	0.000105	0.000375	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000105	0.000374	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—lung cancer	0.000104	0.000374	CcSEcCtD
Zaleplon—Somnolence—Etoposide—lung cancer	0.000104	0.000373	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—lung cancer	0.000104	0.000372	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—lung cancer	0.000104	0.000372	CcSEcCtD
Zaleplon—Insomnia—Paclitaxel—lung cancer	0.000104	0.000372	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—lung cancer	0.000104	0.000371	CcSEcCtD
Zaleplon—Paraesthesia—Paclitaxel—lung cancer	0.000103	0.000369	CcSEcCtD
Zaleplon—Hypertension—Docetaxel—lung cancer	0.000103	0.000368	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—lung cancer	0.000103	0.000368	CcSEcCtD
Zaleplon—Dyspnoea—Paclitaxel—lung cancer	0.000102	0.000366	CcSEcCtD
Zaleplon—Somnolence—Paclitaxel—lung cancer	0.000102	0.000365	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—lung cancer	0.000102	0.000364	CcSEcCtD
Zaleplon—Arthralgia—Docetaxel—lung cancer	0.000102	0.000363	CcSEcCtD
Zaleplon—Myalgia—Docetaxel—lung cancer	0.000102	0.000363	CcSEcCtD
Zaleplon—Chest pain—Docetaxel—lung cancer	0.000102	0.000363	CcSEcCtD
Zaleplon—Nausea—Vinorelbine—lung cancer	0.000101	0.000363	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Etoposide—lung cancer	0.000101	0.000362	CcSEcCtD
Zaleplon—Dyspepsia—Paclitaxel—lung cancer	0.000101	0.000362	CcSEcCtD
Zaleplon—Body temperature increased—Cisplatin—lung cancer	0.000101	0.000362	CcSEcCtD
Zaleplon—Asthenia—Irinotecan—lung cancer	0.000101	0.000361	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000101	0.000361	CcSEcCtD
Zaleplon—Constipation—Etoposide—lung cancer	0.0001	0.000358	CcSEcCtD
Zaleplon—Pain—Etoposide—lung cancer	0.0001	0.000358	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—lung cancer	9.99e-05	0.000357	CcSEcCtD
Zaleplon—Decreased appetite—Paclitaxel—lung cancer	9.98e-05	0.000357	CcSEcCtD
Zaleplon—Dry mouth—Docetaxel—lung cancer	9.93e-05	0.000355	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Paclitaxel—lung cancer	9.91e-05	0.000355	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—lung cancer	9.87e-05	0.000353	CcSEcCtD
Zaleplon—Asthenia—Gemcitabine—lung cancer	9.84e-05	0.000352	CcSEcCtD
Zaleplon—Pain—Paclitaxel—lung cancer	9.82e-05	0.000351	CcSEcCtD
Zaleplon—Constipation—Paclitaxel—lung cancer	9.82e-05	0.000351	CcSEcCtD
Zaleplon—Confusional state—Docetaxel—lung cancer	9.81e-05	0.000351	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—lung cancer	9.75e-05	0.000349	CcSEcCtD
Zaleplon—Anaphylactic shock—Docetaxel—lung cancer	9.73e-05	0.000348	CcSEcCtD
Zaleplon—Oedema—Docetaxel—lung cancer	9.73e-05	0.000348	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—lung cancer	9.72e-05	0.000348	CcSEcCtD
Zaleplon—Pruritus—Gemcitabine—lung cancer	9.7e-05	0.000347	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—lung cancer	9.66e-05	0.000346	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—lung cancer	9.65e-05	0.000345	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—lung cancer	9.63e-05	0.000345	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—lung cancer	9.58e-05	0.000343	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—lung cancer	9.58e-05	0.000343	CcSEcCtD
Zaleplon—Shock—Docetaxel—lung cancer	9.57e-05	0.000343	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—lung cancer	9.54e-05	0.000342	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—lung cancer	9.51e-05	0.00034	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—lung cancer	9.5e-05	0.00034	CcSEcCtD
Zaleplon—Feeling abnormal—Paclitaxel—lung cancer	9.46e-05	0.000339	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—lung cancer	9.45e-05	0.000338	CcSEcCtD
Zaleplon—Gastrointestinal pain—Paclitaxel—lung cancer	9.39e-05	0.000336	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—lung cancer	9.33e-05	0.000334	CcSEcCtD
Zaleplon—Dizziness—Irinotecan—lung cancer	9.31e-05	0.000333	CcSEcCtD
Zaleplon—Urticaria—Etoposide—lung cancer	9.3e-05	0.000333	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—lung cancer	9.28e-05	0.000332	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—lung cancer	9.28e-05	0.000332	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—lung cancer	9.26e-05	0.000331	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—lung cancer	9.26e-05	0.000331	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—lung cancer	9.26e-05	0.000331	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—lung cancer	9.23e-05	0.00033	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—lung cancer	9.21e-05	0.000329	CcSEcCtD
Zaleplon—Asthenia—Cisplatin—lung cancer	9.17e-05	0.000328	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—lung cancer	9.13e-05	0.000327	CcSEcCtD
Zaleplon—Urticaria—Paclitaxel—lung cancer	9.12e-05	0.000326	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—lung cancer	9.09e-05	0.000325	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—lung cancer	9.08e-05	0.000325	CcSEcCtD
Zaleplon—Abdominal pain—Paclitaxel—lung cancer	9.08e-05	0.000325	CcSEcCtD
Zaleplon—Body temperature increased—Paclitaxel—lung cancer	9.08e-05	0.000325	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—lung cancer	9.01e-05	0.000322	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—lung cancer	8.98e-05	0.000321	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—lung cancer	8.92e-05	0.000319	CcSEcCtD
Zaleplon—Rash—Irinotecan—lung cancer	8.88e-05	0.000318	CcSEcCtD
Zaleplon—Dermatitis—Irinotecan—lung cancer	8.87e-05	0.000317	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—lung cancer	8.87e-05	0.000317	CcSEcCtD
Zaleplon—Chills—Methotrexate—lung cancer	8.86e-05	0.000317	CcSEcCtD
Zaleplon—Headache—Irinotecan—lung cancer	8.82e-05	0.000316	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—lung cancer	8.8e-05	0.000315	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—lung cancer	8.74e-05	0.000313	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—lung cancer	8.72e-05	0.000312	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—lung cancer	8.68e-05	0.00031	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—lung cancer	8.65e-05	0.00031	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—lung cancer	8.65e-05	0.00031	CcSEcCtD
Zaleplon—Rash—Gemcitabine—lung cancer	8.65e-05	0.000309	CcSEcCtD
Zaleplon—Dermatitis—Gemcitabine—lung cancer	8.64e-05	0.000309	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—lung cancer	8.59e-05	0.000308	CcSEcCtD
Zaleplon—Headache—Gemcitabine—lung cancer	8.59e-05	0.000307	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—lung cancer	8.57e-05	0.000307	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—lung cancer	8.51e-05	0.000304	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—lung cancer	8.46e-05	0.000303	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—lung cancer	8.42e-05	0.000301	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—lung cancer	8.42e-05	0.000301	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—lung cancer	8.4e-05	0.000301	CcSEcCtD
Zaleplon—Asthenia—Etoposide—lung cancer	8.4e-05	0.000301	CcSEcCtD
Zaleplon—Nausea—Irinotecan—lung cancer	8.36e-05	0.000299	CcSEcCtD
Zaleplon—Pain—Docetaxel—lung cancer	8.32e-05	0.000298	CcSEcCtD
Zaleplon—Constipation—Docetaxel—lung cancer	8.32e-05	0.000298	CcSEcCtD
Zaleplon—Back pain—Methotrexate—lung cancer	8.31e-05	0.000297	CcSEcCtD
Zaleplon—Pruritus—Etoposide—lung cancer	8.29e-05	0.000296	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—lung cancer	8.24e-05	0.000295	CcSEcCtD
Zaleplon—Asthenia—Paclitaxel—lung cancer	8.24e-05	0.000295	CcSEcCtD
Zaleplon—Nausea—Gemcitabine—lung cancer	8.15e-05	0.000291	CcSEcCtD
Zaleplon—Pruritus—Paclitaxel—lung cancer	8.12e-05	0.000291	CcSEcCtD
Zaleplon—Rash—Cisplatin—lung cancer	8.06e-05	0.000288	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—lung cancer	8.05e-05	0.000288	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—lung cancer	8.02e-05	0.000287	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—lung cancer	7.99e-05	0.000286	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—lung cancer	7.97e-05	0.000285	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—lung cancer	7.97e-05	0.000285	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—lung cancer	7.96e-05	0.000285	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—lung cancer	7.94e-05	0.000284	CcSEcCtD
Zaleplon—Malaise—Methotrexate—lung cancer	7.75e-05	0.000277	CcSEcCtD
Zaleplon—Dizziness—Etoposide—lung cancer	7.74e-05	0.000277	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—lung cancer	7.72e-05	0.000276	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—lung cancer	7.72e-05	0.000276	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—lung cancer	7.69e-05	0.000275	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—lung cancer	7.69e-05	0.000275	CcSEcCtD
Zaleplon—Chills—Doxorubicin—lung cancer	7.67e-05	0.000274	CcSEcCtD
Zaleplon—Dizziness—Paclitaxel—lung cancer	7.59e-05	0.000272	CcSEcCtD
Zaleplon—Nausea—Cisplatin—lung cancer	7.59e-05	0.000272	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—lung cancer	7.55e-05	0.00027	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—lung cancer	7.49e-05	0.000268	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—lung cancer	7.44e-05	0.000266	CcSEcCtD
Zaleplon—Rash—Etoposide—lung cancer	7.38e-05	0.000264	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—lung cancer	7.38e-05	0.000264	CcSEcCtD
Zaleplon—Headache—Etoposide—lung cancer	7.34e-05	0.000263	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—lung cancer	7.33e-05	0.000262	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—lung cancer	7.32e-05	0.000262	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—lung cancer	7.32e-05	0.000262	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—lung cancer	7.32e-05	0.000262	CcSEcCtD
Zaleplon—Tension—Doxorubicin—lung cancer	7.3e-05	0.000261	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—lung cancer	7.29e-05	0.000261	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.27e-05	0.00026	CcSEcCtD
Zaleplon—Rash—Paclitaxel—lung cancer	7.24e-05	0.000259	CcSEcCtD
Zaleplon—Dermatitis—Paclitaxel—lung cancer	7.23e-05	0.000259	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—lung cancer	7.23e-05	0.000259	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—lung cancer	7.23e-05	0.000259	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—lung cancer	7.2e-05	0.000258	CcSEcCtD
Zaleplon—Headache—Paclitaxel—lung cancer	7.19e-05	0.000257	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—lung cancer	7.07e-05	0.000253	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—lung cancer	7.01e-05	0.000251	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—lung cancer	6.98e-05	0.00025	CcSEcCtD
Zaleplon—Nausea—Etoposide—lung cancer	6.96e-05	0.000249	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—lung cancer	6.91e-05	0.000247	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—lung cancer	6.89e-05	0.000246	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—lung cancer	6.88e-05	0.000246	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—lung cancer	6.88e-05	0.000246	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—lung cancer	6.84e-05	0.000245	CcSEcCtD
Zaleplon—Nausea—Paclitaxel—lung cancer	6.82e-05	0.000244	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—lung cancer	6.81e-05	0.000244	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—lung cancer	6.78e-05	0.000243	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—lung cancer	6.71e-05	0.00024	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—lung cancer	6.69e-05	0.000239	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—lung cancer	6.69e-05	0.000239	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—lung cancer	6.67e-05	0.000239	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—lung cancer	6.58e-05	0.000235	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—lung cancer	6.55e-05	0.000235	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—lung cancer	6.54e-05	0.000234	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—lung cancer	6.44e-05	0.00023	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—lung cancer	6.43e-05	0.00023	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—lung cancer	6.39e-05	0.000229	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—lung cancer	6.34e-05	0.000227	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—lung cancer	6.34e-05	0.000227	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—lung cancer	6.34e-05	0.000227	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—lung cancer	6.34e-05	0.000227	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—lung cancer	6.31e-05	0.000226	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—lung cancer	6.3e-05	0.000225	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.29e-05	0.000225	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—lung cancer	6.26e-05	0.000224	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—lung cancer	6.25e-05	0.000224	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—lung cancer	6.24e-05	0.000223	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—lung cancer	6.2e-05	0.000222	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—lung cancer	6.17e-05	0.000221	CcSEcCtD
Zaleplon—Rash—Docetaxel—lung cancer	6.14e-05	0.00022	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—lung cancer	6.13e-05	0.000219	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—lung cancer	6.12e-05	0.000219	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—lung cancer	6.1e-05	0.000218	CcSEcCtD
Zaleplon—Headache—Docetaxel—lung cancer	6.1e-05	0.000218	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—lung cancer	6.07e-05	0.000217	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—lung cancer	6.07e-05	0.000217	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—lung cancer	6.06e-05	0.000217	CcSEcCtD
Zaleplon—Pain—Methotrexate—lung cancer	6e-05	0.000215	CcSEcCtD
Zaleplon—Shock—Doxorubicin—lung cancer	5.98e-05	0.000214	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—lung cancer	5.96e-05	0.000213	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—lung cancer	5.93e-05	0.000212	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—lung cancer	5.9e-05	0.000211	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—lung cancer	5.87e-05	0.00021	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—lung cancer	5.79e-05	0.000207	CcSEcCtD
Zaleplon—Nausea—Docetaxel—lung cancer	5.78e-05	0.000207	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—lung cancer	5.78e-05	0.000207	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—lung cancer	5.74e-05	0.000205	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—lung cancer	5.68e-05	0.000203	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—lung cancer	5.57e-05	0.000199	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—lung cancer	5.54e-05	0.000198	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—lung cancer	5.54e-05	0.000198	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.53e-05	0.000198	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—lung cancer	5.49e-05	0.000197	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—lung cancer	5.45e-05	0.000195	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—lung cancer	5.41e-05	0.000194	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—lung cancer	5.4e-05	0.000193	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—lung cancer	5.35e-05	0.000191	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—lung cancer	5.28e-05	0.000189	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—lung cancer	5.24e-05	0.000188	CcSEcCtD
Zaleplon—Pain—Doxorubicin—lung cancer	5.19e-05	0.000186	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—lung cancer	5.19e-05	0.000186	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—lung cancer	5.03e-05	0.00018	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—lung cancer	5.01e-05	0.000179	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—lung cancer	4.97e-05	0.000178	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—lung cancer	4.96e-05	0.000178	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—lung cancer	4.83e-05	0.000173	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—lung cancer	4.8e-05	0.000172	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—lung cancer	4.8e-05	0.000172	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—lung cancer	4.64e-05	0.000166	CcSEcCtD
Zaleplon—Rash—Methotrexate—lung cancer	4.42e-05	0.000158	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—lung cancer	4.42e-05	0.000158	CcSEcCtD
Zaleplon—Headache—Methotrexate—lung cancer	4.39e-05	0.000157	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—lung cancer	4.36e-05	0.000156	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—lung cancer	4.3e-05	0.000154	CcSEcCtD
Zaleplon—Nausea—Methotrexate—lung cancer	4.17e-05	0.000149	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—lung cancer	4.02e-05	0.000144	CcSEcCtD
Zaleplon—Rash—Doxorubicin—lung cancer	3.83e-05	0.000137	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—lung cancer	3.83e-05	0.000137	CcSEcCtD
Zaleplon—Headache—Doxorubicin—lung cancer	3.8e-05	0.000136	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—lung cancer	3.61e-05	0.000129	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—SDC4—lung cancer	3.55e-05	0.000432	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.52e-05	0.000428	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.47e-05	0.000422	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MDM2—lung cancer	3.43e-05	0.000417	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—RAF1—lung cancer	3.41e-05	0.000416	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERCC2—lung cancer	3.39e-05	0.000413	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	3.35e-05	0.000408	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB3—lung cancer	3.32e-05	0.000404	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD17B10—lung cancer	3.31e-05	0.000404	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—lung cancer	3.29e-05	0.0004	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—lung cancer	3.28e-05	0.0004	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	3.26e-05	0.000397	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	3.24e-05	0.000395	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RRM1—lung cancer	3.23e-05	0.000393	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA3—lung cancer	3.23e-05	0.000393	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—APOA1—lung cancer	3.2e-05	0.00039	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAT—lung cancer	3.2e-05	0.00039	CbGpPWpGaD
Zaleplon—AOX1—Disease—TERT—lung cancer	3.18e-05	0.000387	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCB1—lung cancer	3.11e-05	0.000379	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGFR1—lung cancer	3.09e-05	0.000376	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CKB—lung cancer	3.08e-05	0.000375	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—HRAS—lung cancer	3.07e-05	0.000374	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TYMS—lung cancer	3.06e-05	0.000372	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIF1A—lung cancer	3.04e-05	0.00037	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—B4GALT5—lung cancer	3.04e-05	0.00037	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—lung cancer	3.02e-05	0.000368	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	3e-05	0.000366	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	2.98e-05	0.000363	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA4—lung cancer	2.95e-05	0.00036	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOA1—lung cancer	2.93e-05	0.000357	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	2.93e-05	0.000357	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.9e-05	0.000353	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CNDP2—lung cancer	2.9e-05	0.000353	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM2—lung cancer	2.9e-05	0.000353	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA2—lung cancer	2.88e-05	0.000351	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	2.88e-05	0.00035	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	2.86e-05	0.000349	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1A1—lung cancer	2.86e-05	0.000349	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.86e-05	0.000348	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	2.86e-05	0.000348	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ERCC2—lung cancer	2.84e-05	0.000346	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTMR3—lung cancer	2.82e-05	0.000343	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	2.81e-05	0.000342	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA1—lung cancer	2.78e-05	0.000338	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCC3—lung cancer	2.75e-05	0.000335	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PGAM1—lung cancer	2.75e-05	0.000334	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.71e-05	0.00033	CbGpPWpGaD
Zaleplon—AOX1—Disease—KIT—lung cancer	2.68e-05	0.000326	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—lung cancer	2.68e-05	0.000326	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.67e-05	0.000325	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C1—lung cancer	2.66e-05	0.000324	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGF—lung cancer	2.65e-05	0.000322	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.63e-05	0.00032	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A7—lung cancer	2.62e-05	0.000319	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—UGT1A1—lung cancer	2.58e-05	0.000315	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SDC4—lung cancer	2.56e-05	0.000312	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	2.56e-05	0.000312	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.54e-05	0.00031	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	2.54e-05	0.000309	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.53e-05	0.000308	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.53e-05	0.000308	CbGpPWpGaD
Zaleplon—AOX1—Disease—BRAF—lung cancer	2.52e-05	0.000307	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.49e-05	0.000304	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNG11—lung cancer	2.49e-05	0.000303	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6R—lung cancer	2.49e-05	0.000303	CbGpPWpGaD
Zaleplon—AOX1—Disease—CREBBP—lung cancer	2.48e-05	0.000302	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.48e-05	0.000302	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOA1—lung cancer	2.46e-05	0.000299	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	2.45e-05	0.000299	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	2.38e-05	0.00029	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOA—lung cancer	2.37e-05	0.000289	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAP2K1—lung cancer	2.37e-05	0.000289	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	2.36e-05	0.000288	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—lung cancer	2.35e-05	0.000287	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—lung cancer	2.35e-05	0.000286	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RRM1—lung cancer	2.33e-05	0.000284	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA3—lung cancer	2.33e-05	0.000284	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	2.32e-05	0.000283	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA3—lung cancer	2.3e-05	0.00028	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	2.3e-05	0.00028	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—lung cancer	2.24e-05	0.000273	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG2—lung cancer	2.24e-05	0.000273	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADCY1—lung cancer	2.24e-05	0.000273	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.22e-05	0.000271	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AZIN2—lung cancer	2.22e-05	0.000271	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—lung cancer	2.2e-05	0.000268	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HPGDS—lung cancer	2.2e-05	0.000267	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO2—lung cancer	2.2e-05	0.000267	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—B4GALT5—lung cancer	2.2e-05	0.000267	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—lung cancer	2.19e-05	0.000267	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPP2R1B—lung cancer	2.18e-05	0.000266	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.17e-05	0.000264	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	2.15e-05	0.000262	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—lung cancer	2.15e-05	0.000262	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	2.14e-05	0.00026	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA4—lung cancer	2.14e-05	0.00026	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—POMC—lung cancer	2.13e-05	0.00026	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—lung cancer	2.13e-05	0.000259	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—lung cancer	2.11e-05	0.000257	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GCLC—lung cancer	2.1e-05	0.000256	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2A6—lung cancer	2.1e-05	0.000256	CbGpPWpGaD
Zaleplon—AOX1—Disease—RAF1—lung cancer	2.1e-05	0.000256	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	2.1e-05	0.000256	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA2—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CREBBP—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTOR—lung cancer	2.05e-05	0.00025	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—lung cancer	2.05e-05	0.00025	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD4—lung cancer	2.05e-05	0.000249	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—lung cancer	2.03e-05	0.000248	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	2.03e-05	0.000247	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA1—lung cancer	2.01e-05	0.000245	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO1—lung cancer	2e-05	0.000243	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCC3—lung cancer	1.99e-05	0.000242	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—lung cancer	1.97e-05	0.00024	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—lung cancer	1.95e-05	0.000237	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C1—lung cancer	1.92e-05	0.000234	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ATP5H—lung cancer	1.89e-05	0.00023	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—POMC—lung cancer	1.88e-05	0.000229	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—lung cancer	1.88e-05	0.000229	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UGT1A1—lung cancer	1.87e-05	0.000227	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	1.84e-05	0.000224	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNG11—lung cancer	1.8e-05	0.000219	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2E1—lung cancer	1.79e-05	0.000218	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—lung cancer	1.78e-05	0.000216	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—lung cancer	1.77e-05	0.000216	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NQO1—lung cancer	1.77e-05	0.000216	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—lung cancer	1.72e-05	0.000209	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOA—lung cancer	1.71e-05	0.000209	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—lung cancer	1.7e-05	0.000207	CbGpPWpGaD
Zaleplon—AOX1—Disease—EP300—lung cancer	1.69e-05	0.000206	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLBD1—lung cancer	1.68e-05	0.000205	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA3—lung cancer	1.66e-05	0.000203	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—lung cancer	1.64e-05	0.0002	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADCY1—lung cancer	1.62e-05	0.000197	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG2—lung cancer	1.62e-05	0.000197	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—STK11—lung cancer	1.6e-05	0.000194	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HPGDS—lung cancer	1.59e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO2—lung cancer	1.59e-05	0.000193	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—lung cancer	1.59e-05	0.000193	CbGpPWpGaD
Zaleplon—AOX1—Disease—NRAS—lung cancer	1.58e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.58e-05	0.000192	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B10—lung cancer	1.54e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—lung cancer	1.54e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A6—lung cancer	1.52e-05	0.000185	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCLC—lung cancer	1.52e-05	0.000185	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—lung cancer	1.52e-05	0.000185	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—lung cancer	1.49e-05	0.000181	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—lung cancer	1.48e-05	0.00018	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—lung cancer	1.47e-05	0.000179	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO1—lung cancer	1.44e-05	0.000176	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—lung cancer	1.44e-05	0.000176	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAT—lung cancer	1.44e-05	0.000175	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CKB—lung cancer	1.43e-05	0.000174	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—EP300—lung cancer	1.42e-05	0.000172	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—lung cancer	1.4e-05	0.00017	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMS—lung cancer	1.37e-05	0.000167	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—lung cancer	1.36e-05	0.000166	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—lung cancer	1.36e-05	0.000165	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CNDP2—lung cancer	1.35e-05	0.000164	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM2—lung cancer	1.35e-05	0.000164	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTMR3—lung cancer	1.31e-05	0.00016	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2E1—lung cancer	1.29e-05	0.000158	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—lung cancer	1.29e-05	0.000157	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NQO1—lung cancer	1.28e-05	0.000156	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PGAM1—lung cancer	1.28e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ERCC2—lung cancer	1.28e-05	0.000155	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—lung cancer	1.25e-05	0.000152	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A7—lung cancer	1.22e-05	0.000148	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SDC4—lung cancer	1.19e-05	0.000145	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—lung cancer	1.16e-05	0.000141	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—STK11—lung cancer	1.15e-05	0.00014	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—lung cancer	1.11e-05	0.000135	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA1—lung cancer	1.1e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA3—lung cancer	1.09e-05	0.000132	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RRM1—lung cancer	1.09e-05	0.000132	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—lung cancer	1.07e-05	0.00013	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—lung cancer	1.05e-05	0.000128	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAT—lung cancer	1.04e-05	0.000126	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—lung cancer	1.02e-05	0.000124	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—B4GALT5—lung cancer	1.02e-05	0.000124	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—lung cancer	1.01e-05	0.000123	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—lung cancer	1.01e-05	0.000123	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA4—lung cancer	9.93e-06	0.000121	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMS—lung cancer	9.92e-06	0.000121	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—lung cancer	9.8e-06	0.000119	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA2—lung cancer	9.67e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—POMC—lung cancer	9.59e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CREBBP—lung cancer	9.34e-06	0.000114	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA1—lung cancer	9.33e-06	0.000114	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—lung cancer	9.29e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCC3—lung cancer	9.23e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ERCC2—lung cancer	9.22e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C1—lung cancer	8.94e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—lung cancer	8.85e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—lung cancer	8.74e-06	0.000106	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGT1A1—lung cancer	8.68e-06	0.000106	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—lung cancer	8.56e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNG11—lung cancer	8.37e-06	0.000102	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA1—lung cancer	7.97e-06	9.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOA—lung cancer	7.97e-06	9.7e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA3—lung cancer	7.73e-06	9.42e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—lung cancer	7.72e-06	9.4e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—lung cancer	7.65e-06	9.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADCY1—lung cancer	7.52e-06	9.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG2—lung cancer	7.52e-06	9.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPGDS—lung cancer	7.38e-06	8.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO2—lung cancer	7.38e-06	8.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.33e-06	8.93e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—lung cancer	7.28e-06	8.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—lung cancer	7.16e-06	8.72e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A6—lung cancer	7.07e-06	8.62e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCLC—lung cancer	7.07e-06	8.62e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—POMC—lung cancer	6.93e-06	8.44e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CREBBP—lung cancer	6.75e-06	8.22e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO1—lung cancer	6.71e-06	8.17e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—lung cancer	6.67e-06	8.12e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—lung cancer	6.4e-06	7.8e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—EP300—lung cancer	6.36e-06	7.75e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—lung cancer	6.32e-06	7.7e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2E1—lung cancer	6.01e-06	7.33e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NQO1—lung cancer	5.95e-06	7.24e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—lung cancer	5.58e-06	6.79e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—lung cancer	5.53e-06	6.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—STK11—lung cancer	5.36e-06	6.53e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—lung cancer	4.96e-06	6.04e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAT—lung cancer	4.83e-06	5.88e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—lung cancer	4.82e-06	5.87e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—lung cancer	4.7e-06	5.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—lung cancer	4.7e-06	5.72e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMS—lung cancer	4.61e-06	5.62e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EP300—lung cancer	4.6e-06	5.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—lung cancer	4.56e-06	5.55e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—lung cancer	4.32e-06	5.26e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ERCC2—lung cancer	4.29e-06	5.22e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—lung cancer	3.84e-06	4.68e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA1—lung cancer	3.71e-06	4.52e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—lung cancer	3.4e-06	4.14e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—lung cancer	3.38e-06	4.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—POMC—lung cancer	3.22e-06	3.92e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CREBBP—lung cancer	3.14e-06	3.82e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—lung cancer	2.98e-06	3.62e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—lung cancer	2.94e-06	3.58e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—lung cancer	2.78e-06	3.38e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—lung cancer	2.59e-06	3.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—lung cancer	2.57e-06	3.13e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—lung cancer	2.24e-06	2.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EP300—lung cancer	2.14e-06	2.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—lung cancer	1.58e-06	1.93e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—lung cancer	1.29e-06	1.57e-05	CbGpPWpGaD
